Detailed price information for Medallion Fin Corp (MFIN-Q) from The Globe and Mail including charting and trades.

H. Lundbeck A/S (Lundbeck) today announced the acceptance of its new drug application (NDA) for Vyepti® (eptinezumab) by the Ministry of Health, Labor and Welfare (MHLW) in Japan.

September 30, 2025 Cash and Cash Equivalents at $10 million Revenue Expected to Grow in 2026 and Continue to Offset Cash Burn Management to Host Conference Call Today at 4:30 p.m. ET MOUNTAIN VIEW, ...

As financial planning software takes a bigger role in guiding client decisions, advisors can use the new tools to build scale ...

Few life milestones are as emotionally and financially transformative as becoming a parent. While this chapter is often filled with deep joy, it can also bring new worries as each stage of parenthood ...

A Management Report reviewing the Company’s third quarter 2025 financial results will be furnished to the Securities and ...

SAN CARLOS, CALIFORNIA / ACCESS Newswire / November 6, 2025 / By setting solid financial goals, you'll find it easier to achieve the lifestyle and future you desire. Financial goals can help you ...